Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M183,129Revenue (TTM) $M39,807Net Margin (%)14.3Altman Z-Score--
Enterprise Value $M183,129EPS (TTM) $2.0Operating Margin %22.5Piotroski F-Score--
P/E(ttm)32.7Beneish M-Score--Pre-tax Margin (%)18.8Higher ROA y-yN
Price/Book4.210-y EBITDA Growth Rate %-7.4Quick Ratio--Cash flow > EarningsN
Price/Sales4.75-y EBITDA Growth Rate %-31.5Current Ratio--Lower Leverage y-yN
Price/Free Cash Flow32.6y-y EBITDA Growth Rate %-92.0ROA % (ttm)5.7Higher Current Ratio y-yN
Dividend Yield %2.8PEG--ROE % (ttm)12.9Less Shares Outstanding y-yN
Payout Ratio %94.0Shares Outstanding M2,757ROIC % (ttm)12.0Gross Margin Increase y-yN

Gurus Latest Trades with MRK

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

MRK is held by these investors:



MRK: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Karachun Rita ASr. VP Fince-Global Controller 2017-02-14Sell2,954$64.732.61view
RUSSO PATRICIA FDirector 2017-02-08Sell5,000$64.423.1view
WEEKS WENDELL PDirector 2017-02-06Sell5,000$64.512.96view
WENDELL PETER CDirector 2017-02-03Sell15,000$63.694.29view
Holston Michael JEVP, General Counsel 2017-02-03Sell91,959$63.963.85view
Schechter Adam HEVP & Pres-Global Human Health 2017-02-03Sell36,335$63.734.22view
Cech Thomas RDirector 2017-02-03Sell5,000$63.424.73view
FRAZIER KENNETH CChairman, President & CEO 2016-11-10Sell140,000$65.032.14view
Gerberding Julie L.EVP Strat Comm, Gl Pub Policy 2016-11-07Sell85,523$60.0210.66view
LAZARUS ROCHELLE BDirector 2016-11-02Sell20,000$59.0612.46view

Press Releases about MRK :

Quarterly/Annual Reports about MRK:

News about MRK:

Articles On GuruFocus.com
Why 3D Printing and Biotech Will Be Good Bets in 2017 Feb 23 2017 
Dow Jones Closes at 20,504.41 Feb 15 2017 
Nasdaq Reaches a New High on Wednesday Feb 08 2017 
Merck: Analyzing 2016 Performance and Outlook for 2017 Feb 04 2017 
Is Bristol-Meyers a Buy After 39% Price Decline? Jan 29 2017 
US Market Indexes Lower on Monday Jan 24 2017 
US Market Indexes Lower for the Week Jan 21 2017 
US Market Indexes Higher After Trump Press Conference Jan 11 2017 
US Market Indexes Trade Flat Jan 10 2017 
Gilead Sciences Must Answer to Investors After a Disappointing 2016 Jan 05 2017 

More From Other Websites
Big Pharma Pushes Back on Drug-Price Complaints Mar 01 2017
How Gilead’s Liver Disease Drugs Portfolio Performed Mar 01 2017
AstraZeneca’s Symbicort: Dominant Player in Inhaler Segment Mar 01 2017
[$$] Cancer Test Makers Raise Nearly $1 Billion Mar 01 2017
Emerging Markets Expected to Be AstraZeneca’s Key Growth Driver Mar 01 2017
AstraZeneca’s New Products May Offer 2017 Growth Opportunities Mar 01 2017
Label Expansion Expected to Boost Keytruda’s 2017 Revenue Mar 01 2017
Cramer Remix: How drug stocks fulfilled their destiny wit... Feb 28 2017
[$$] OrbiMed Logs Two Decades of Novel Attacks on Cancer Feb 28 2017
Cramer: This Drug Rally Is No Longer 'Trumped Up' Feb 28 2017
MERCK & CO., INC. Files SEC form 10-K, Annual Report Feb 28 2017
AstraZeneca Expects Fall in Net Profit Margins in 2017 Feb 28 2017
Why AstraZeneca’s Revenues Are Expected to Fall in 2017 Feb 28 2017
Merck Announces Second-Quarter 2017 Dividend Feb 28 2017
What Analysts Are Recommending for AstraZeneca in 2017 Feb 28 2017
Recent Survey Finds Many Adults with Diabetes Unaware of Their Increased Risk for Certain Serious... Feb 28 2017
UK rejects Merck's Keytruda as initial treatment for lung cancer Feb 28 2017
UK rejects Merck's Keytruda as initial treatment for lung cancer Feb 28 2017
Januvia, Vaccines May Drive Merck’s Revenue Growth in 2017 Feb 28 2017
Respiratory Segment: AstraZeneca’s Growth Platform Feb 28 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)